Influence of beta-blocker coadministration on the kinetics of isosorbide mononitrate and dinitrate
- 1 December 1986
- journal article
- research article
- Published by Springer Nature in Klinische Wochenschrift
- Vol. 64 (23), 1213-1216
- https://doi.org/10.1007/bf01734458
Abstract
The influence of beta-blocker coadministration on the kinetics of oral isosorbide-5-mononitrate (ISMN) and isosorbide dinitrate (ISDN) was studied in healthy volunteers. In the first study, 12 subjects ingested 20 mg ISMN on three occasions in the control state, during coadministration of metipranolol (20 mg 3 times daily), or during metoprolol (100 mg twice daily). There were no significant differences among the three phases in peak serum ISMN concentration (470 ng/ml), the time of peak (0.6 h after dose), elimination half-life (4.5 h), or oral clearance (142 ml/min). In the second study, 10 subjects received 20 mg ISDN in the control state and again during coadministration of propranolol (80 mg 3 times daily). There were no differences between the two phases in peak serum ISDN concentration (20 ng/ml) or the time of peak (0.6 h). Propranolol increased, although not significantly, ISDN clearance (16.5 vs 12.3 L/min,P<0.1), and had no effect on total area under the curve for ISMN, the major metabolite of ISDN. Thus, therapeutic doses of these beta-blockers have a minimal influence on the kinetics of single doses of ISMN or ISDN in healthy individuals.This publication has 19 references indexed in Scilit:
- Kinetics of 1,2-dinitroglycerin following sustained release nitroglycerin: Influence of propranolol and metoprololKlinische Wochenschrift, 1985
- Determination of the two mononitrate metabolites of isosorbide dinitrate in human plasma and urine by gas chromatography with electron-capture detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1984
- Clinical Pharmacokinetics of Organic NitratesClinical Pharmacokinetics, 1983
- Determination of deacetylmetipranolol in body fluids by gas chromatography—chemical-ionization mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Plasma concentrations and bioavailability of isosorbide dinitrate and pindolol from a combination formulationBiopharmaceutics & Drug Disposition, 1981
- Kinetics of isosorbide dinitrate and relationships to pharmacological effects.British Journal of Clinical Pharmacology, 1981
- Pharmacokinetics of intravenous and oral isosorbide-5-mononitrateEuropean Journal of Clinical Pharmacology, 1981
- Reduction in Lidocaine Clearance during Continuous Infusion and by Coadministration of PropranololNew England Journal of Medicine, 1980
- Effects and pharmacokinetics of isosorbide dinitrate in normal manEuropean Journal of Clinical Pharmacology, 1980
- Impairment of antipyrine clearance in humans by propranolol.Circulation, 1978